Annora Pharma, the formulations subsidiary of Hetero Group, has expanded its collaboration with AltiusHub to deploy an AI-native serialization, track-and-trace and regulatory compliance platform across its export operations.

The deployment is aimed at improving serialization efficiency by up to 45% while strengthening operational visibility across Annora Pharma’s global pharmaceutical supply chain. The rollout will support compliance requirements across key export regions including the US, EU, GCC, LATAM and ASEAN markets.

As part of the implementation, Annora Pharma plans to achieve real-time visibility across 100% of its serialized drug products within three months, covering the complete journey from packaging lines to export dispatch.

The unified platform replaces fragmented legacy serialization systems and supports serialization, aggregation and multi-market regulatory reporting while integrating with the company’s existing Level 3 packaging infrastructure.

According to the companies, AltiusHub’s AI-driven analytics and automated exception management capabilities are expected to improve operational efficiency, accelerate issue resolution and strengthen compliance oversight across multiple geographies.

Bhaskar Reddy, Director, Hetero Group, said, “As supply chains become more complex, limited data access in legacy systems is becoming a growing challenge. While technology has advanced, many systems have not kept pace. Today, pharmaceutical companies need solutions that provide greater control over their data and processes.”

“AltiusHub has enabled our teams to manage serialization and traceability workflows with greater transparency, flexibility, and independence,” he added.

Sridhar Reddy, Operations Head, Annora Pharma, said, “We need systems that give our teams real-time visibility, faster issue resolution, and greater control over compliance workflows. AltiusHub has helped us simplify these operations while improving efficiency across the packaging and dispatch process.”

Siddharth Reddy, Managing Director, AltiusHub, said, “For a long time, pharma companies have had to accept that traceability implementations are slow, resource-intensive, and heavily dependent on vendors. AltiusHub’s go-live at Annora Pharma shows that this model is changing.”